The World’s Largest Bio/Pharma Event for Compliance and Legal Professionals

Agenda

CONGRESS PRELUDES Tuesday, April 16, 2019

2:30 – 3:00PM

Prelude Registration

3:00 – 5:00PM

BENEFIT FROM ONE OF THREE TAILORED COMPLIANCE PRELUDES

PRELUDE A Healthcare Compliance and Policy Course

Designed for those new to compliance or new to the bio/pharma industry, this session acts as a primer for the conference as the main program is built off of the key elements discussed. Benefit from foundational knowledge in healthcare compliance basics before you embark on two content rich days covering emerging, high-risk areas.

As scrutiny of nurse educator programs heats up, industry must ensure the proper guardrails are in place to maintain compliance for these critical patient support programs. During this session, gain foundational and operational knowledge needed to structure and maintain compliant programs.

Manny Tzavlakis
Managing PartnerHelio Health Group

Erin Parsons
Health Care Compliance OfficerJanssen Pharmaceuticals

Chuck Bell
Former Compliance OfficerKedrion Biopharma Inc.

Eric Greig
AssociateLatham & Watkins LLP

PRELUDE C Women’s Executive Leadership Forum
Powered by:

This highly-acclaimed Forum showcases women in leadership within the compliance and life sciences community. Hear compelling stories of personal career success, reflect on professional development paths, discover flashpoint moments and ways to inspire and elevate the compliance team. Attendees discover meaningful mentorships and insights into optimal job placement and professional pathways.

John Richter
Partner, King & Spalding LLP;
former Deputy Chief and Assistant U.S. Attorney,U.S. Attorney’s Office, Western District of Oklahoma

Jacob T. Elberg
Associate Professor, Seton Hall University School of Law;
former Assistant U.S. Attorney, U.S. Attorney's Office, District of New Jersey

12:30

Networking Luncheon

CLOSED-DOOR AND INVITATION-ONLY* CHIEF COMPLIANCE OFFICER SUMMIT

HOSTED BY:

ABOUT OUR SUMMIT HOST John Patrick Oroho, Executive Vice President and Chief Strategy Officer of Porzio Life Sciences, LLC, meets regularly with companies to identify sales and marketing issues and to propose solutions that streamline their practices in meeting compliance requirements of all 50 states and the District of Columbia. Mr. Oroho is also a principal of the law firm, Porzio, Bromberg & Newman P.C., and practices in the Life Sciences Compliance and Commercialization Department. He concentrates his law practice in regulatory compliance with respect to the Prescription Drug Marketing Act (PDMA), Anti-Kickback Statute, False Claim Act, and Medicare and Medicaid fraud and abuse. Mr. Oroho previously served as Senior Vice President and General Counsel for the PDMA Alliance, a national trade association focused on sample distribution and pharmaceutical marketing and sales compliance.

*Invited participants hold the title of Chief Compliance Officer, Vice President of Compliance, General Counsel or an equivalent compliance leadership position at a life sciences company (at the time of the congress). Final eligibility approval is at the discretion of CBI.

The CCO Summit provides world-class thought-leadership and is designed to deliver high-quality information that C-suite leaders can develop into an action plan. Collaborate with your distinguished colleagues to gain valuable insights through a blend of innovative, thought-provoking keynotes coupled with an interactive and engaging working group.

Summit Outline:

I. Keynote Address on Ethics and Leadership

Sheelah Kolhatkar
Staff Writer, The New Yorker;
PBS Host, Playing By The Rules

INAUGURAL BENCHMARKING SURVEY RESULTS REVEALED

Exclusive Intelligence on the State of Bio/Pharma Compliance

Benefit from a comprehensive wrap-up of benchmarking results representing the collective intelligence of the compliance community from a sampling of companies (brand/generic, large/small and private/public). Content of the survey covers top priorities and emerging risk areas.

Agenda

CONGRESS PRELUDES Tuesday, April 16, 2019

2:30 – 3:00PM

Prelude Registration

3:00 – 5:00PM

BENEFIT FROM ONE OF THREE TAILORED COMPLIANCE PRELUDES

PRELUDE A Healthcare Compliance and Policy Course

Designed for those new to compliance or new to the bio/pharma industry, this session acts as a primer for the conference as the main program is built off of the key elements discussed. Benefit from foundational knowledge in healthcare compliance basics before you embark on two content rich days covering emerging, high-risk areas.

As scrutiny of nurse educator programs heats up, industry must ensure the proper guardrails are in place to maintain compliance for these critical patient support programs. During this session, gain foundational and operational knowledge needed to structure and maintain compliant programs.

Manny Tzavlakis
Managing PartnerHelio Health Group

Erin Parsons
Health Care Compliance OfficerJanssen Pharmaceuticals

Chuck Bell
Former Compliance OfficerKedrion Biopharma Inc.

Eric Greig
AssociateLatham & Watkins LLP

PRELUDE C Women’s Executive Leadership Forum
Powered by:

This highly-acclaimed Forum showcases women in leadership within the compliance and life sciences community. Hear compelling stories of personal career success, reflect on professional development paths, discover flashpoint moments and ways to inspire and elevate the compliance team. Attendees discover meaningful mentorships and insights into optimal job placement and professional pathways.

John Richter
Partner, King & Spalding LLP;
former Deputy Chief and Assistant U.S. Attorney,U.S. Attorney’s Office, Western District of Oklahoma

Jacob T. Elberg
Associate Professor, Seton Hall University School of Law;
former Assistant U.S. Attorney, U.S. Attorney's Office, District of New Jersey

12:30

Networking Luncheon

CLOSED-DOOR AND INVITATION-ONLY* CHIEF COMPLIANCE OFFICER SUMMIT

HOSTED BY:

ABOUT OUR SUMMIT HOST John Patrick Oroho, Executive Vice President and Chief Strategy Officer of Porzio Life Sciences, LLC, meets regularly with companies to identify sales and marketing issues and to propose solutions that streamline their practices in meeting compliance requirements of all 50 states and the District of Columbia. Mr. Oroho is also a principal of the law firm, Porzio, Bromberg & Newman P.C., and practices in the Life Sciences Compliance and Commercialization Department. He concentrates his law practice in regulatory compliance with respect to the Prescription Drug Marketing Act (PDMA), Anti-Kickback Statute, False Claim Act, and Medicare and Medicaid fraud and abuse. Mr. Oroho previously served as Senior Vice President and General Counsel for the PDMA Alliance, a national trade association focused on sample distribution and pharmaceutical marketing and sales compliance.

*Invited participants hold the title of Chief Compliance Officer, Vice President of Compliance, General Counsel or an equivalent compliance leadership position at a life sciences company (at the time of the congress). Final eligibility approval is at the discretion of CBI.

The CCO Summit provides world-class thought-leadership and is designed to deliver high-quality information that C-suite leaders can develop into an action plan. Collaborate with your distinguished colleagues to gain valuable insights through a blend of innovative, thought-provoking keynotes coupled with an interactive and engaging working group.

Summit Outline:

I. Keynote Address on Ethics and Leadership

Sheelah Kolhatkar
Staff Writer, The New Yorker;
PBS Host, Playing By The Rules

INAUGURAL BENCHMARKING SURVEY RESULTS REVEALED

Exclusive Intelligence on the State of Bio/Pharma Compliance

Benefit from a comprehensive wrap-up of benchmarking results representing the collective intelligence of the compliance community from a sampling of companies (brand/generic, large/small and private/public). Content of the survey covers top priorities and emerging risk areas.